FDA Approves joimax® Intracs®em Electromagnetic Navigation System for Endoscopic Minimally Invasive Spine Surgery

IRVINE, CA – joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is pleased to announce that Intracs® em, its electromagnetic navigation tracking and control system, has been approved by the FDA.

The Intracs® em Navigation System allows for spinal procedures to be carried out with minimal X-ray control, drastically reducing radiation exposure, access time, and the entire length of the surgical procedure. In fact, all joimax® instruments and scopes can be tracked and accurately navigated through the appropriate sensors, which improves safety, expands endoscopic indications, and flattens the learning curve.

Intracs®em is a multiyear development. Its first cadaveric trials were made with a group of surgeons at the ESPINEA® Labs in Karlsruhe, Germany and Irvine, CA.

FDA Approval , joimax endoscopic navigation system Intracs em

According to Prof. Dr. med. Michael Kraus of ORTHIX Zentrum in Augsburg, Germany, who headed the preliminary trials: “Using Intracs® em Navigation System in the full endoscopic spine surgery is safe and easily applicable. The technology helps master precise access to the spine, and the clinical trials have confirmed the technique’s multiple advantages.”

Prof. Dr. Chris Hofstetter of UW Medical Center in Seattle, Washington, USA, adds: “joimax® Intracs®em constitutes a highly precise image-guided navigation platform designed for the specific needs of full-endoscopic spine surgery. Using electromagnetic navigation technology allows to track the leading edge of endoscopic instruments in real time, and facilitates needle targeting and orientation during the surgery, while minimizing radiation exposure. No doubt, this technology will expand the indications for full-endoscopic spine surgery and pave the way for innovations in minimally invasive arthrodesis techniques.”

joimax® is also excited to announce its second joint Global Symposium being held in partnership with Integrity Implants, Inc., August 21 – 22. For details, visit www.joimax.com.

Eurospine 2016: joimax® launches its new MultiZYTE® SI-Joint Endoscopic Therapy Set and its new Intracs® Intraoperative Navigation Tracking & Control System

Karlsruhe – October 05, 2016 – joimax®, the global acting German developer and marketer of technologies and training methods for endoscopic minimally invasive spinal surgery, will again exhibit at Eurospine 2016 taking place from October 5 – 7 in Berlin. During the conference, joimax®will launch two new products – the MultiZYTE® SI Endoscopic Sacroiliac Joint Therapy Set and its new Intracs® Intraoperative Navigation Tracking & Control System.

MultiZYTE® SI Endoscopic Sacroiliac Joint Therapy is developed for the treatment of the Sacroiliac Joint Syndrome (SIJS), which has been rediscovered as a major back pain generator in recent years. This kind of pain is commonly felt in the lower back, the gluteal region, the hip and thigh and can even radiate into the leg and foot. Until the 1930s, SI-Joint was the main reason for low back pain, but since 1934 the focus has been on disc herniation. According to recent studies 15 to 25% of all low back pain is caused by the SI-Joint and up to 43% in patients having undergone lumbosacral fusion. MultiZYTE® SI joimax® now offers a well developed and lasting treatment option for this disease.

The Intracs® Intraoperative Navigation Tracking & Control System was developed in cooperation between joimax® GmbH Karlsruhe and fiagon GmbH in Berlin, both located in Germany. With the Intracs® system, joimax® instruments can be navigated directly at the tip using Fiagons “chip at the tip” technology which allows tracking of instruments with a diameter in the 1mm range. The Intracs ® Navigation and Monitor Unit is integrated in the joimax® Endoscopic Tower and all necessary tools are tailored for the TESSYS® (transforaminal) and iLESSYS® (interlaminar) procedures as well as for minimally invasive stabilization procedures, like EndoLIF® and Percusys®. The main features of the Intracs® system are needle navigation through Vector-Tip-Target processing tools, the merging of 2D X-Rays with 3D- images of a patient’s CT or MRI scans, and the constant orientation control of any endoscope used in joimax procedures.

“With these two new developments we are in the position to enhance our endoscopic minimally-invasive product portfolio, driving adoption rates to meet new heights. With the world unique Intracs® system, navigation is now faster, safer and more accurate than ever before using an electromagnetic (EM) field. Radiation exposure for both, patients and surgeons will be significantly reduced,” says Wolfgang Ries, CEO and founder of joimax®. “Additionally the learning curve for all spinal endoscopic procedures offered by joimax® will now be significantly reduced and the rapid expansion of all these techniques is now well layed-out,” he continues.

joimax® Launches Its Latest Interlaminar Endoscopic System, iLESSYS® Pro, and New 4K Camera Light Source and Documentation Command System, Camsource® LED and Vitegra® at AANS in New Orleans, LA and GSC in Singapore

Karlsruhe, Germany – May 1st 2018 – joimax® again launches new product innovations at the upcoming American Association of Neurological Surgeons (AANS) taking place in New Orleans from April 28 – May 2, and at the Global Spine Congress (GSC) in Singapore, starting May 2. The German based market leader of technologies and training methods for minimally invasive endoscopic spinal surgery expands its family of decompression systems with an additional milestone of its interlaminar endoscopic access systems named iLESSYS® Pro for access and resection within the spinal canal. All endoscopic systems including the members of the so-called iLESSYS® Family will be shown at AANS as well as at GSC, where joimax® will host a full-day workshop with four stations on May 1 and with numerous lectures on endoscopic spine surgery held throughout the congress.

iLESSYS® Pro was developed in collaboration with Christoph Hofstetter, MD, PhD Associate Professor at University of Washington in Seattle, Washington.  It combines the ability to efficiently remove and decompress degenerative spinal pathology from the iLESSYS® Delta with the possibility to enter the spinal canal and treat intraspinal disc pathology which has been a hallmark of the iLESSYS® system. Along with TESSYS®, TESSYS® XT and TESSYS® Isee, now all lumbal and thoracic degenerative pathologies can effectively be treated with joimax® techniques.

“We have re-engineered every part of the iLESSYS® Pro, including dilators, rongeurs and drills with the goal to bring spine endoscopy one step closer to the efficiency of minimally invasive tubular spine surgery. Our patients benefit from the minimal tissue trauma associated with a small working corridor and a low complication rate achieved by superior visualization and illumination by working channel endoscopes. The new scope has completely surpassed my expectations and it is my go-to scope for interlaminar discectomies, medial facetectomies and certain laminectomies.” explains Dr. Christoph Hofstetter.  Also Dr. Ralf Wagner from the Ligamenta Spine Center in Frankfurt, GER expresses his enthusiasm: “The working channel of 4.7 mm allows the use of larger forceps or blades for effective removal of hard tissue and, at the same time, is small enough to ideally suit for working within the spinal canal – really fantastic.”

At both congresses, the company will show its newest combined 4K resolution camera and LED light source system, Camsource® LED and its fully integrated documentation and command system, Vitegra® Docu and Command. They were presented for the first time at the Annual Meeting of the American Association of Orthopedic Surgeons (AAOS) in New Orleans in March. With these innovations, joimax® again sets a major milestone worldwide. “With a significant growth rate in Q1/2018 we clearly demonstrate our leading role in endoscopic spinal surgery. We are still approaching our goal: to sustainably anchor the endoscopic minimally invasive spine surgery” states Wolfgang Ries, Founder and CEO of joimax®. “This is also reflected in the increase of accepted lectures held at all congresses accompanied by a steadily growing number of publications”.

joimax®announces major spike in attendance at its ESPINEA® workshops, reports record revenues

Karlsruhe (GER) — German-based joimax®, the market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is excited to announce a major spike in attendance at its Endoscopic Spine Academy (ESPINEA®) workshops, which contributes to sustainable growth after another year of record revenues in 2021.

The growing interest can be attributed to increased coverage in literature and publications as cited on PubMed®. Moreover, the joimax® initiated workshop program, now under the umbrella of ESPINEA®, offers optimal training for a variety of applications and procedures, making it attractive to a broader audience.

Joimax Growth in education.

joimax® established ESPINEA® three years ago. In Fall 2020, the Endoscopic Spine Academy was accredited by the Royal College of Surgeons Edinburgh (RCSEd). It is one of only four Accreditation Centers that meet its strict rigorous internal quality assurance processes. Together, with its growing team of faculty, joimax® developed the complete six-step curriculum to bridge the learning curve for spine surgeons. The curriculum, which was approved by the RCSEd, is developed as an educational program from beginners to masters alike.

J.N. Alastair Gibson DSc MD FRCSEd, a RCSEd and ESPINEA® Advisory Board Member sums it up: “The ESPINEA® mission is to serve endoscopic spine surgeons by providing a growing global network for lifelong learning to best benefit the patient. Our vision is to be the world’s leading interdisciplinary community in endoscopic spine surgery.”

In addition to holding ESPINEA® courses at the joimax®-owned premises in Karlsruhe (Germany) and Irvine (USA), they are also held at ORSI Academy (Belgium) and at other prestigious universities, such as Paracelsus Medical University Salzburg (Austria). Recently, ESPINEA® was rolled out in Thailand. Prior to the July PASMISS Meeting, the courses will be launched in Singapore for the APAC region, and following the October SMISS Meeting, launched widely in the U.S.

“Given the ongoing development of endoscopic spine surgery with more and more technological options, the benefits for the patients, along with the substantial publication, I am convinced that endoscopic spine surgery is now the gold standard,” states Iprenburg Spine Clinic Founder and ESPINEA® Advisory Board Member Dr. Menno Iprenburg.

With the ESPINEA® courses, surgeons can train on different procedures using the joimax® TESSYS®, iLESSYS®, CESSYS®, MultiZYTE®, EndoLIF®, Percusys® based on the latest NAVENTO® tower. Most of the courses are conducted in a hybrid mode — online and on-site presentations and lectures combined with in-person hands-on training using models, simulators and anatomical specimens.

ESPINEA® was established as an open education platform for other players in the field of spinal surgery as well. Therefore, further supporters have already joined and new entrants are welcomed.

DWG 2016 in Hannover, Germany: joimax® shows major presence with daily lunch symposia and Meet the Expert Sessions at its booth

Karlsruhe, Germany – December 8th, 2016 – from Dec 1st to 3rd, 2016 the most important German spine congress has taken place at the Hannover Congress Centre. joimax® as global acting German developer and marketer of technologies and training methods for endoscopic minimally invasive spinal surgery again exhibited at the 11th congress of the German Spine Society (DWG). The congress attracted an increasing number of attendees who gathered for the latest news on spinal surgery as well as to learn about the techniques and results of endoscopic spine surgery and the benefits of these techniques for both the surgeon and their patients.

DWG 2016
joimax® presence at DWG 2016

joimax® presented its complete product range including the newly launched MultiZYTE® RT (e.g. for rhizotomy) as well as MultiZYTE® SI for Sacroiliac Joint therapy and the Intracs® Interaoperative Navigation Tracking & Control System. With Intracs®, a fully endoscopic integrated electromagnetic based system, the joimax® instruments can be navigated directly at the tip which allows tracking of instruments with a diameter in the 1mm range. In the course of the congress joimax® also held two well attended lunch symposia covering the whole scope of surgical indications and also the field of pain therapy up to decompression. Furthermore joimax® offered daily “Meet the Expert”-Sessions at its booth where spine surgeons were given the possibility to participate on the extensive experience of well-known German spine specialists.

“The endoscopic minimally invasive techniques are becoming more and more the first choice in spinal surgery. This is also reflected in the steadily and now fast growing number of studies showing the benefits on this treatment modalities”, says Wolfgang Ries, CEO and founder of joimax®. The most recent study by Alastair Gibson, MD from Edinburgh, Scotland called “A randomized controlled trial of TED vs Microdiscectomy” has recently been published online in the European Spine Journal.  During his long-time use of joimax® endoscopic systems and educational work Dr. Gibson published a huge number of studies on endoscopic minimally invasive spinal surgery. Lately in October 2016 joimax®, together with the Paracelsus Medical University (PMU), had the honor of conferring him with the Parviz Kambin Award for his excellence in endoscopic spinal surgery. This event took place during the CME-certified workshop course held at the PMU in Salzburg, Austria. The Award is presented to pioneers in the field of endoscopic minimally invasive spine surgery, to which group of Awardees Alastair Gibson was elected there.

Perviz Kambin Award 2016 ; Alastair Gibson
From left to right: Dr. Menno Iprenburg, NL; Awardee Alastair Gibson, MD, Scotland; Dr. Ralf Wagner, Germany; Wolfgang Ries, Founder & CEO joimax® GmbH

joimax® Introduces Intracs® em Electromagnetic Navigation System – New Minimally Invasive Device Exhibited at EUROSPINE Barcelona and NASS Los Angeles

Irvine, Calif. — joimax®, the Germany-based market leader of technologies and training methods for full-endoscopic spinal surgery, introduces another minimally invasive device, Intracs® em Electromagnetic Navigation System, at two global spine events: EUROSPINE Barcelona, the Spine Society of Europe’s annual conference and expo (September 19-21), and NASS 2018, the North American Spine Society premier meeting in Los Angeles (September 24-28).

“With developments such as Intracs® em, we are steadily positioning ourselves as true innovators in this space.”, states Wolfgang Ries, Founder and CEO of joimax®, “And we further strengthen our leading role in endoscopic spinal surgery.” he adds.

Intracs® em Electromagnetic Navigation System

Intracs® em relies on electromagnetic tracking and is specifically designed for simple and safe access to any spinal target. For exceptional accuracy, the instruments are vector-guided directly at the tip; therefore, bending of needles or other pliant instruments will not affect the navigation’s precision. The new smart and user-friendly system can serve as a stand-alone device, or be completely integrated with the joimax® Endoscopic Tower. It is the only system on the market which allows for simultaneous navigation of multiple instruments such as needles, guiding rods, reamers, and endoscopes; developed by joimax®.

The full European product launch is scheduled for Q4 2018. The global launch, including the United States, will be rolled out in the beginning of 2019.

Trade Show Exhibitions and Demo Workshops

joimax® will be exhibiting at EUROSPINE 2018 and NASS 2018.

  • EUROSPINE 2018: On September 20, joimax® will present at a lunch symposium. In addition, members of the internationally acclaimed joimax® faculty group will host daily Meet the Expert sessions at the joimax® booth, No. 05A.
  • NASS 2018: On September 27, the company will be part of the After Hours Workshop presentation and hands-on cadaver lab. Plus, following a successful introduction at the Annual Meeting of the American Association of Orthopedic Surgeons (AAOS) in New Orleans last March, joimax® will showcase its combined 4K UHD resolution camera and LED light source system, Camsource® LED, and the fully integrated documentation and command system, Vitegra® Docu and Command. Presentations held at Booth No. 1529.

joimax® Experiences Major Growth, Launches TESSYS® TransSAP Endoscopic Surgical System

KARLSRUHE, Germany – (BUSINESS WIRE) – joimax® is continuing its year-over-year double digit growth. Over the past 9 months, joimax® has grown more than 25% globally and in the United States alone, more than 35%. Among this major spurt, the market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery is launching a new endoscopic surgical system, TESSYS® TransSAP.

“This allows for more extensive foraminal decompression and provides an optimal basis for transforaminal endoscopic fusion”

The company attributes strong growth to their popular workshop and educational program, which is now offered worldwide under the ESPINEA® training academy. To keep momentum, joimax® is releasing the TESSYS® TransSAP — the fourth addition to the TESSYS® family encompassing the standard TESSYS® Std, TESSYS® XT featuring longer reach instruments, and TESSYS® Thx, the optimized version for the thoracic spine.

The system is based on the proven TESSYS® method introduced in 2004. Since then, the technology has been enhanced and can be used for more complex indications, widening the spectrum of disease and vertebral level applications.

joimax® faculty surgeon masters, Dr. Christof Hofstetter and Dr. Ralf Wagner, demonstrate TESSYS® and iLESSYS® to an at capacity crowd during NASS 2022 in Chicago. (Photo: Business Wire)

“The TransSAP method follows an adopted access path to the spine, directly targeting the Superior Articulating Process,” says Dr. Christoph Hofstetter, associate professor in the Department of Neurological Surgery at the University of Washington. “This allows for more extensive foraminal decompression and provides an optimal basis for transforaminal endoscopic fusion,” adds Dr. Ralf Wagner, a longstanding joimax® ESPINEA® Faculty orthopedic surgeon based in Frankfurt.

In addition, joimax® provides a series of implants for fusion indications, such as the percutaneous pedicle screw system, Percusys® Plus, and a family of 3D-printed titanium cages within the EndoLIF® program. The EndoLIF® suite of products consists of the static implants O/On-Cage, Delta-Cage and DoubleWedge-Cage. “There are plans to add a new fully-expandable cage, as well as a navigated solution for endoscopic disc preparation and implant positioning to provide a full endoscopic assisted fusion platform,” says Wolfgang Ries, CEO and founder of joimax®.

All joimax® implants can be safely inserted using the “Over-the-Wire” technique for precise implantation, making them ideal for endoscopically-assisted fusion procedures established and protected by joimax®.

These new products have been exhibited at the following trade shows: SMISS in Las Vegas, CNS in San Francisco, and NASS in Chicago, and will be featured at EUROSPINE in Milan and at the German Spine Congress, DWG, in Berlin later this year.

joimax® obtains full product registration in Thailand, and is now active in 10 Asian countries

Karlsruhe, Germany – February 27th, 2017 – joimax® further ensures its market access in Asia. The German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery is expanding its presence and recently has obtained full product registration from the Thai Food & Drug Administration (FDA). joimax® also has approvals in South Korea, China, Singapore, Indonesia, Hong Kong and Vietnam. For Malaysia, Taiwan and Japan, the certification for the product range is expected in 2017. “We are constantly pushing the registration process in Asia to extend the availability of joimax® products. Thus, joimax® is well prepared to further widen its market presence in Asia, demonstrating our commitment to the fastest growing region of the world,” states Wolfgang Ries, Founder and CEO of joimax®.

For years, joimax® has been working with the Korean Wooridul group, the world’s largest Specialized Spine Hospital Network. Starting in 2017, joimax®, together with the Wooridul Hospital in Seoul, will offer International courses for Minimally Invasive Spinal Surgery (MISS). In a series of four courses, provided in basic and advanced level, the education of international spine surgeons is ensured. The first one, chaired by joimax® faculty Dr. Sang-Ho Lee, South Korea, recently took place. The one-week training programs offer surgeons the opportunity to learn percutaneous endoscopic techniques and other minimally-invasive procedures with lectures, operation observation and hands-on-workshops. Since 2004, more than 600 spine surgeons and specialists from 41 countries have participated in these courses at Wooridul.

Participants of the National Minimal Invasive Spinal Summit Forum & 4th joimax User Meeting, held in Zhenghou City, China from Dec. 23rd until 25th, 2016
Participants of the National Minimal Invasive Spinal Summit Forum & 4th joimax User Meeting, held in Zhenghou City, China from Dec. 23rd until 25th, 2016

After the National Minimal Invasive Spinal Summit Forum, together with the 4th joimax® User Meeting in December, joimax® China, headquartered in Chengdu, will celebrate its 10th birthday in April 2017. On this occasion, numerous internationally well-known faculties will meet in Chongqing, China to share experience and expertise. Lectures and live surgeries are planned to be held in two hospitals and to be broadcasted via Internet.

Endoscopy in Pain Therapy – One day meeting with live surgery – Rome, Nov 24, 2018

Endoscopy in Pain Therapy

Focus on Facet Joint – Sacroiliac Joint – Peripheral nerves
New Endoscopic Approach

The aim of the Course of Endoscopy in Pain Therapy is to develop endoscopic techniques in the treatment of common diseases like Low Back Pain, Sacroileitis and Peripheral nerves pain. This course gives the participants an overview of endoscopic possibilities and new approaches in Pain Therapy.

The course is divided in two sessions, a frontal didactical part with an explanation of anatomy and physiopathology of facet joint pain, sacroliliac pain and peripheral nerves disturbs, and it is followed by a practice part with 2 / 3 surgical procedures performed by Dr. Meloncelli and his equipe with a direct explanation of surgical aspects.

At a glance:

One day meeting with live surgery
Rome, November 24, 2018, 9:30 – 17:00

Course director: Dr. Stefano Meloncelli
Secretary: Dr. Ignazio Urti
Faculty: Dr. Marco Divizia, Dr. Giorgio Germani

Location:
Casa di Cura „Valle Giulia“
Via Guiseppe de Notaris 2, Roma
www.clinicavallegiulia.it

Number of Participants: 10
Subscription: 600 Euro

Reservation and information:
Medical Training
phone number:+39 329 771 41 69
email: infomedicaltraining@gmail.com

sponsored by

Diemme ; Dr Meloncelli
SMS Device ; Dr Meloncelli

joimax® Announces Executive Appointments Among Record-Breaking Sales for 2022

KARLSRUHE, Germany – (BUSINESS WIRE) – joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, has appointed Mr. Maximilian Ries and Mr. Anthony Troncale to new executive positions, effective January 1. The announcement comes among record-breaking sales across Europe, Asia, and the United States in 2022.

Maximilian Ries

Ries took on the newly created role of Executive Vice President, Business Development and Operations at joimax®. In this position, based in Germany, he will be responsible for scaling global operations to ensure joimax® continues its exponential growth. Formerly the General Manager, for the past six of his 13-year tenure with joimax®, Ries built out the United States and Latin American markets.

Tony Troncale

Troncale was promoted to General Manager; he was formerly Vice President of Marketing and Business Development at joimax® Inc. Over the past two years, Troncale, in addition to increasing his responsibilities, successfully capitalized on the significant interest in endoscopic techniques to expand US sales operations. He joined joimax® in 2021 bringing 20-years of experience in the spinal device industry where he served in sales and marketing leadership roles at Stryker, K2M, and Synthes Spine. Contributing to the global organization’s continuous strong sales growth was the launch of a new surgical access system, “Tessys® Trans SAP” and the global expansion of the ESPINEA® Education Academy.

Wolfgang Ries

“I am extremely pleased with our 2022 global performance and the significant interest in endoscopic spine surgery,” stated joimax® Founder and CEO Wolfgang Ries. “With Max and Tony in their new roles, our market-leading endoscopic spine technologies, and our anticipated launch of two more new surgical access systems later in 2023, we are well positioned for another very successful year.”